Benzoic acid,2-(broMoMethyl)-5-fluoro-3-nitro-, Methyl ester – (850462-65-6)

Napabucasin, 83280-65-3, 2-Acetylfuro-1, 4-naphthoquinone, 2-acetylnaphtho[2, 3-b]furan-4, 9-dione, BBI608, 2-acetylbenzo[f][1]benzofuran-4, 9-dione, BBI-608, 2-Acetyl-4H, 9H-naphtho[2, 3-b]furan-4, 9-dione, 2-Acetylfuranonaphthoquinone, Z1HHM49K7O, BBI 608, 2-Acetylnaphtho(2, 3-b)furan-4, 9-dione, Napabucasin [USAN:INN], UNII-Z1HHM49K7O, Napabucasina, Napabucasine, FNQ, MFCD28155270, Napabucasin BBI608, Napabucasin (BBI608), NAPABUCASIN [INN], NAPABUCASIN [JAN], NAPABUCASIN [USAN], Napabucasin (BBI608)?, NAPABUCASIN [WHO-DD], CHEMBL64130, Napabucasin (JAN/USAN/INN), SCHEMBL1883845, GTPL11358, DPHUWDIXHNQOSY-UHFFFAOYSA-N, BCP07628, EX-A1314, IDA28065, BDBM50366597, NSC788900, NSC816092, s7977, AKOS027470201, CCG-266871, CS-1747, DB12155, NSC-788900, NSC-816092, AC-32935, AS-60519, DA-65928, HY-13919, 2-Acetyl-naphtho[2, 3-b]furan-4, 9-dione, A3110, Cancer cell stemness inhibitor (Napabucasin), NS00070834, D10717, EN300-207428, F17379, BRD-K22064724-001-01-8, NAPHTHO(2, 3-B)FURAN-4, 9-DIONE, 2-ACETYL-, Q27294876, Z2027914355